Tue, January 2, 2024

Jason Gerberry Maintained (XENE) at Strong Buy with Increased Target to $56 on, Jan 2nd, 2024

Jason Gerberry of B of A Securities, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy with Increased Target from $52 to $56 on, Jan 2nd, 2024.

Jason has made no other calls on XENE in the last 4 months.



There are 5 other peers that have a rating on XENE. Out of the 5 peers that are also analyzing XENE, 0 agree with Jason's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Jason


  • Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $62 on, Monday, December 18th, 2023
  • Brian Skorney of "Baird" Initiated at Buy and Held Target at $63 on, Friday, December 8th, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $56 on, Tuesday, November 28th, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $46 on, Thursday, November 9th, 2023
  • Josh Schimmer of "Cantor Fitzgerald" Initiated at Buy on, Tuesday, October 24th, 2023